Difference between revisions of "Team:Marburg/Design"

Line 125: Line 125:
 
                         <figcaption>
 
                         <figcaption>
 
                           Fig.1: Approach for reintroducing the natural competence of Li <i>et al.</i>, 2018. The pilN-Gene gets
 
                           Fig.1: Approach for reintroducing the natural competence of Li <i>et al.</i>, 2018. The pilN-Gene gets
                           integrated via homologous recombination into the neutral site II(NS II), together with a
+
                           integrated via homologous recombination into the neutral site II (NS II), together with a
 
                           Chloramphenicol-resistance-cassette (cm Res).
 
                           Chloramphenicol-resistance-cassette (cm Res).
 
                         </figcaption>
 
                         </figcaption>
 
                       </figure>
 
                       </figure>
 
                       <p style="margin-top: 1em;">
 
                       <p style="margin-top: 1em;">
                         Although we did not prefer this method, we still tried it, as we were not sure, if our other
+
                         Although we did not prefer this method, we still tried, as we were not sure, if our other
 
                         approach would prove to be successful. We also used extensive bioinformatic tools to identify
 
                         approach would prove to be successful. We also used extensive bioinformatic tools to identify
                         <a href="https://2019.igem.org/Team:Marburg/Parts">new integration sites</a> in UTEX 2973, which
+
                         <a href="https://2019.igem.org/Team:Marburg/Model#anso" target="_blank">new integration sites</a> in UTEX 2973, which
 
                         can be used if one were to reintroduce natural competence in the above mentioned way.
 
                         can be used if one were to reintroduce natural competence in the above mentioned way.
 
                         Additionally, we came up with a plan to revert the point mutation in the <i>pilN</i> gene with a
 
                         Additionally, we came up with a plan to revert the point mutation in the <i>pilN</i> gene with a
Line 149: Line 149:
 
                         This approach is promising, as the integration of the new <i>pilN</i> copy only enabled a low
 
                         This approach is promising, as the integration of the new <i>pilN</i> copy only enabled a low
 
                         efficiency of natural transformation, which might be due to the point mutation negatively
 
                         efficiency of natural transformation, which might be due to the point mutation negatively
                         affecting expression of the <i>pil0</i> and <i>pilQ</i> genes laying downstream of <i>pilN</i>
+
                         affecting expression of the <i>pilO</i> and <i>pilQ</i> genes laying downstream of <i>pilN</i>
                         <a href="https://academic.oup.com/femsle/article/129/1/83/442013">(Li et al., 2018 ; Barten and
+
                         <a href="https://academic.oup.com/femsle/article/129/1/83/442013">(Li <i>et al.</i>, 2018 ; Barten and
 
                           Lill, 1995)</a>. As CRISPR/Cas12a allows accurate targeting of genetic sequences, we designed
 
                           Lill, 1995)</a>. As CRISPR/Cas12a allows accurate targeting of genetic sequences, we designed
 
                         a
 
                         a
                         crRNA leading the Cas12a protein to the <i>pilN</i> locus. The repair template was taken from
+
                         gRNA leading the Cas12a protein to the <i>pilN</i> locus. The repair template was taken from
                         the <i>S. elongatus</i> PCC 7042 genome, where the gene is still intact, allowing the cell to
+
                         the <i>S. elongatus</i> PCC 7942 genome, where the gene is still intact, allowing the cell to
 
                         repair the cut introduced by Cas12a accordingly, reversing the point mutation, which leads to an
 
                         repair the cut introduced by Cas12a accordingly, reversing the point mutation, which leads to an
 
                         intact copy of <i>pilN</i> again - a more elegant approach than simply inserting a second copy
 
                         intact copy of <i>pilN</i> again - a more elegant approach than simply inserting a second copy
                         of the gene. As our own CRISPR system was still in building at that point, we had to rely on
+
                         of the gene. As our own CRISPR system was still under construction at that point, we had to rely on
 
                         pSL2680, a replicating base vector for constructing CRISPR/Cas12a editing plasmids by
 
                         pSL2680, a replicating base vector for constructing CRISPR/Cas12a editing plasmids by
 
                         <a href="https://www.nature.com/articles/srep39681">Ungerer and Pakrasi, 2016</a>.<br>
 
                         <a href="https://www.nature.com/articles/srep39681">Ungerer and Pakrasi, 2016</a>.<br>
 
                         We followed their protocol <a href="https://www.addgene.org/85581">(available here on
 
                         We followed their protocol <a href="https://www.addgene.org/85581">(available here on
                           Addgene)</a>, annealing oligos to construct the crRNA. Small overhangs were added to enable
+
                           Addgene)</a>, annealing oligos to construct the gRNA. Small overhangs were added to enable
 
                         the
 
                         the
 
                         ligation into the AarI-digested vector, where a <i>lacZ</i> cassette was replaced, which allowed
 
                         ligation into the AarI-digested vector, where a <i>lacZ</i> cassette was replaced, which allowed
                         for blue/white screening of recombinant colonies. This cloning step alone took approximately a
+
                         for blue/white screening of recombinant colonies. Additionally, the repair template had to be constructed by PCR with added overhangs for
                        week. Additionally, the repair template had to be constructed by PCR with added overhangs for
+
 
                         the following Gibson reaction. As stated, it was taken from the <i>S. elongatus</i> PCC 7942
 
                         the following Gibson reaction. As stated, it was taken from the <i>S. elongatus</i> PCC 7942
 
                         genome. It was designed in such a way that the point mutation inside the UTEX 2973 genome was
 
                         genome. It was designed in such a way that the point mutation inside the UTEX 2973 genome was
Line 176: Line 175:
 
                           alt="blub">
 
                           alt="blub">
 
                         <figcaption>
 
                         <figcaption>
                           Fig.3: The Top of the Figure shows a part of the pilN gene of UTEX 2973. You can
+
                           Fig.3: The top of the figure shows a part of the pilN gene of UTEX 2973. You can
                           clearly see the Mutation which causes the STOP-Codon. Additionally the PAM-sequence and the
+
                           clearly see the mutation which causes the STOP-Codon. Additionally the PAM-sequence and the
                           target region of Cas12a are visible. The sequence in the middle is from the PCC 7942. This
+
                           target region of Cas12a are visible. The sequence in the middle is from the strain PCC 7942. This
 
                           sequence differs in just one basepair, but this basepair has the effect, that the pilN gene is
 
                           sequence differs in just one basepair, but this basepair has the effect, that the pilN gene is
 
                           working in PCC 7942. Additionally the PAM-site of Cas12a does not appear in PCC 7942, due to
 
                           working in PCC 7942. Additionally the PAM-site of Cas12a does not appear in PCC 7942, due to
Line 186: Line 185:
 
                       </figure>
 
                       </figure>
 
                       <p style="margin-top: 1em;">
 
                       <p style="margin-top: 1em;">
                         After the successful Gibson assembly of crRNA and repair template into the Cas12a carrying
+
                         After the successful Gibson assembly of gRNA and repair template into the Cas12a carrying
 
                         vector, nearly two weeks had passed, indicating that working with this vector can be quite
 
                         vector, nearly two weeks had passed, indicating that working with this vector can be quite
 
                         tedious and time consuming. This is one of the many reasons why we chose to implement such a
 
                         tedious and time consuming. This is one of the many reasons why we chose to implement such a
Line 209: Line 208:
 
                   <div class="content-inner">
 
                   <div class="content-inner">
 
                     <p>
 
                     <p>
                       CRISPR/Cas systems are powerful tools that have gained a lot of popularity in the recent years.
+
                       CRISPR/Cas systems are powerful tools that have gained a lot of popularity in recent years.
 
                       As they can be used for a wide array of applications - like the integration of whole genes,
 
                       As they can be used for a wide array of applications - like the integration of whole genes,
                       alteration of single nucleotides, knock-outs of whole genetic regions, as well as the use of the
+
                       alternation of single nucleotides, knock-outs of whole genetic regions, as well as the use of the
 
                       DNA-binding property in a multitude of applications through so called deadCas systems, where the
 
                       DNA-binding property in a multitude of applications through so called deadCas systems, where the
 
                       Cas protein does not exhibit nuclease activity
 
                       Cas protein does not exhibit nuclease activity
                       <a href="https://www.cell.com/action/showPdf?pii=S0092-8674%2814%2900604-7">(Hsuet al., 2014)</a>
+
                       <a href="https://www.cell.com/action/showPdf?pii=S0092-8674%2814%2900604-7">(Hsu <i>et al.</i>, 2014)</a>
 
                       - we were eager to implement such a system into our own
 
                       - we were eager to implement such a system into our own
                       <a href="https://2019.igem.org/Team:Marburg/Design">toolbox</a>. Diving into the literature we
+
                       <a href="https://2019.igem.org/Team:Marburg/Design#toolbox">toolbox</a>. Diving into literature we
                       noticed many different systems are available,the most commonly used one being CRISPR/Cas9, and we
+
                       noticed many different systems are available, the most commonly used one being CRISPR/Cas9, and we
 
                       began to wonder which of them we should use.<br>
 
                       began to wonder which of them we should use.<br>
                       In our <a href="https://2019.igem.org/Team:Marburg/Description">description</a> we presented
+
                       In our <a href="https://2019.igem.org/Team:Marburg/Description#strain_engineering">description</a> we presented
 
                       CRISPR/Cas9 and CRISPR/Cas12a, showing the differences of these two systems. Looking deeper into
 
                       CRISPR/Cas9 and CRISPR/Cas12a, showing the differences of these two systems. Looking deeper into
 
                       CRISPR/Cas12a we noticed a few advantages that finally led us to choose it as our preferred
 
                       CRISPR/Cas12a we noticed a few advantages that finally led us to choose it as our preferred
Line 231: Line 230:
 
                       For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed
 
                       For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed
 
                       from different vectors or a multi cassette vector (
 
                       from different vectors or a multi cassette vector (
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058">X. Ma et
+
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058">X. Ma <i>et
                         al., 2015</a>;
+
                         al.</i>, 2015</a>;
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104"> Z. Zhang
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104"> Z. Zhang
                         et al., 2016 </a> ). In contrary, multiplexed genome editing with Cas12a can be achieved simply
+
                         <i>et al.</i>, 2016 </a> ). In contrary, multiplexed genome editing with Cas12a can be achieved simply
                       by expressing all of the needed guide RNAs in one transcriptional unit, where they are then
+
                       by expressing all of the needed guide RNAs in one transcriptional unit, the crRNA.
                      processed into different crRNAs by Cas12a
+
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0065">(Kim, et
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0065">(Kim, et
                         al., 2016; Nishimasu et al., 2017)</a>. This is a huge advantage of Cas12a. Furthermore,
+
                         al., 2016; Nishimasu <i>et al.</i>, 2017)</a>. This is a huge advantage of Cas12a. Furthermore,
 
                       CRISPR/Cas9 was shown to be toxic in cyanobacteria
 
                       CRISPR/Cas9 was shown to be toxic in cyanobacteria
 
                       <a href="https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7">
 
                       <a href="https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7">
                         (Wendt et al., 2016)</a>, which is one of the foremost reasons CRISPR technologies have not been
+
                         (Wendt <i>et al.</i>, 2016)</a>, which is one of the foremost reasons CRISPR technologies have not been
                       widely applied in cyanobacteria - the usage of Cas12a though, does not seem to have the same
+
                       widely applied in cyanobacteria - the usage of Cas12a though, seems to be less
                       toxicity <a href="https://www.nature.com/articles/srep39681"> Ungerer and Pakrasi, 2016 </a>,
+
                       toxic <a href="https://www.nature.com/articles/srep39681"> (Ungerer and Pakrasi, 2016)</a>,
 
                       making it the ideal candidate for the Green Extension of the
 
                       making it the ideal candidate for the Green Extension of the
 
                       <a href="https://2019.igem.org/Team:Marburg/Parts">Marburg Collection</a>.<br>
 
                       <a href="https://2019.igem.org/Team:Marburg/Parts">Marburg Collection</a>.<br>
 
                       The actual implementation of the CRISPR/Cas12a system into our toolbox necessitated a well thought
 
                       The actual implementation of the CRISPR/Cas12a system into our toolbox necessitated a well thought
 
                       out plan. The design of our CRISPR/Cas12a system was mainly affected by the fact that we wanted to
 
                       out plan. The design of our CRISPR/Cas12a system was mainly affected by the fact that we wanted to
                       have a convenient and rapid tool for genomic manipulation. The lvl 0 part (What are parts? Read
+
                       have a convenient and rapid tool for genomic manipulation. The lvl 0 <a href="https://2019.igem.org/Team:Marburg/Basic_Part">part</a> of the
                      more about it click <a href="https://2019.igem.org/Team:Marburg/Basic_Part">here!</a>) of the
+
 
                       Cas12a protein was created via PCR amplification from the plasmid pSL2680, but special overhangs
 
                       Cas12a protein was created via PCR amplification from the plasmid pSL2680, but special overhangs
 
                       were added in order to clone the PCR product into a lvl 0 acceptor vector. The part was introduced
 
                       were added in order to clone the PCR product into a lvl 0 acceptor vector. The part was introduced

Revision as of 15:57, 8 December 2019

D E S I G N



"Always plan ahead. It wasn’t raining when Noah build the ark." - Richard Cushing


What does expanding the Golden Gate based Marburg Collection, automating time consuming lab work and establishing the CRISPR/Cas12a system in Synechococcus elongatus UTEX 2973 have in common?
To achieve these objectives, it is always necessary to have a comprehensive theoretical preparation. It all starts with literature research, summarizing the current state of the art and based on this developing own ideas. To have the theoretical background settled, before the lab work starts, is a key point of every project and consumes many hours.
Because in the near future phototrophic organisms will be more and more relevant for biotechnological applications, we want to establish the use of Synechococcus elongatus as a phototrophic organism for Synthetic Biology. Following the principles of Synthetic Biology to simplify the process of engineering of biological systems, we set it our goal to establish Synechococcus elongatus UTEX 2973 as the fastest and most accessible phototrophic chassis to date, providing it as a wind tunnel for phototrophic organisms with user friendly and standardized workflows.
In order to achieve these goals, a lot of effort has been put into designing, building, testing, evaluating and learning. Further, these steps had to be iterated over and over again to elaborate our standardized designs. By providing you our theoretical background we want to give you an insight in our decision-making.


S T R A I N
E N G I N E E R I N G


We modified Synechococcus elongatus UTEX 2973 to establish the CRISPR/Cas12a system in our organism.

T O O L B O X


We expanded last years Marburg Collection and made the parts suitable for Synechococcus elongatus UTEX 2973.